Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -78.16% is 28% above its 5-year average of -108.73%, near the high end of its 5-year range (-251.20%–-32.95%).
As of the fiscal period ended Tuesday, June 30, 2026. 12.19% above its 12-month average of -89.01%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -78.16%.
RETURN ON INVESTED CAPITAL (ROIC)
-78.16%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-89.01%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-115.40%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-108.73%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-59.56%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+12.19%
CURRENT VS 3Y AVG
+32.27%
CURRENT VS 5Y AVG
+28.11%
CURRENT VS 10Y AVG
-31.24%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.77%
median of 761 covered companies
CURRENT VS SECTOR MEDIAN
-124.79%
vs the sector median at left
Kyntra Bio, Inc.
Market Cap
$24.09M
Return on Invested Capital (ROIC)
-78.16%
TTM Avg
-89.01%
3Y Avg
-115.40%
5Y Avg
-108.73%
Market Cap
$24.67M
Return on Invested Capital (ROIC)
-146.30%
TTM Avg
-66.51%
3Y Avg
-47.74%
5Y Avg
-43.26%
Market Cap
$24.70M
Return on Invested Capital (ROIC)
-53.34%
TTM Avg
-80.89%
3Y Avg
-129.43%
5Y Avg
-113.96%
Market Cap
$22.98M
Return on Invested Capital (ROIC)
-36.89%
TTM Avg
-112.27%
3Y Avg
-56.18%
5Y Avg
-37.49%
Market Cap
$25.29M
Return on Invested Capital (ROIC)
-59.10%
TTM Avg
-35.54%
3Y Avg
-33.20%
5Y Avg
-24.47%
Market Cap
$22.36M
Return on Invested Capital (ROIC)
-248.21%
TTM Avg
-225.06%
3Y Avg
-147.38%
5Y Avg
-102.77%
Market Cap
$22.11M
Return on Invested Capital (ROIC)
-14.21%
TTM Avg
-12.54%
3Y Avg
-12.42%
5Y Avg
-37.50%
Market Cap
$21.76M
Return on Invested Capital (ROIC)
-253.57%
TTM Avg
-160.85%
3Y Avg
-171.27%
5Y Avg
-226.34%
Market Cap
$20.99M
Return on Invested Capital (ROIC)
-27.14%
TTM Avg
-181.80%
3Y Avg
-158.13%
5Y Avg
-129.64%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kyntra Bio, Inc. (KYNB) | $24.09M | -78.16% | -89.01% | -115.40% | -108.73% |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.67M | -146.30% | -66.51% | -47.74% | -43.26% |
| ABVC BioPharma, Inc. (ABVC)vs › | $24.70M | -53.34% | -80.89% | -129.43% | -113.96% |
| Rein Therapeutics Inc. (RNTX)vs › | $22.98M | -36.89% | -112.27% | -56.18% | -37.49% |
| iTonic Holdings Ltd. (ITOC)vs › | $25.29M | -59.10% | -35.54% | -33.20% | -24.47% |
| LeonaBio, Inc. (LONA)vs › | $22.36M | -248.21% | -225.06% | -147.38% | -102.77% |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.11M | -14.21% | -12.54% | -12.42% | -37.50% |
| Modular Medical, Inc. (MODD)vs › | $21.76M | -253.57% | -160.85% | -171.27% | -226.34% |
| Quantum BioPharma Ltd. (QNTM)vs › | $20.99M | -27.14% | -181.80% | -158.13% | -129.64% |
| Seres Therapeutics, Inc. (MCRB)vs › | $27.78M | -103.04% | -97.88% | -84.76% | -65.40% |
ROIC
-78.2%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -78.16% |
| 2026-03-31 | -55.11% |
| 2025-12-31 | -50.80% |
| 2025-09-30 | -120.34% |
| 2025-06-30 | -140.66% |
| 2025-03-31 | -184.74% |
| 2024-12-31 | -251.20% |
| 2024-09-30 | -225.42% |
| 2024-06-30 | -147.47% |
| 2024-03-31 | -137.36% |
| 2023-12-31 | -136.87% |
| 2023-09-30 | -117.04% |
| 2023-06-30 | -100.90% |
| 2023-03-31 | -110.69% |
| 2022-12-31 | -89.45% |
| 2022-09-30 | -103.72% |
| 2022-06-30 | -50.51% |
| 2022-03-31 | -57.30% |
| 2021-12-31 | -52.62% |
| 2021-09-30 | -32.95% |
| 2021-06-30 | -39.93% |
| 2021-03-31 | -29.22% |
| 2020-12-31 | -28.91% |
| 2020-09-30 | -33.78% |
| 2020-06-30 | -43.76% |
| 2020-03-31 | -16.03% |
| 2019-12-31 | -11.82% |
| 2019-09-30 | 3.82% |
| 2019-06-30 | 4.91% |
| 2019-03-31 | -13.21% |
| 2018-12-31 | -10.95% |
| 2018-09-30 | -17.27% |
| 2018-06-30 | -15.87% |
| 2018-03-31 | -16.81% |
| 2017-12-31 | -14.93% |
| 2017-09-30 | -15.74% |
| 2017-06-30 | -24.06% |
| 2017-03-31 | -15.26% |
| 2016-12-31 | -13.27% |
| 2016-09-30 | -16.68% |
| 2016-06-30 | -21.38% |
| 2016-03-31 | -15.53% |
| 2015-12-31 | -19.24% |
| 2015-09-30 | -17.52% |
| 2015-06-30 | -14.75% |
| 2015-03-31 | -21.13% |
| 2014-12-31 | -11.91% |
| 2014-09-30 | -9.30% |
| 2014-06-30 | 15.67% |
| 2014-03-31 | -2.22% |
| 2013-12-31 | -3.06% |
